WO2011105349A1 - 2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネートの安定型結晶およびその製造方法並びにその結晶を含有する農薬組成物 - Google Patents
2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネートの安定型結晶およびその製造方法並びにその結晶を含有する農薬組成物 Download PDFInfo
- Publication number
- WO2011105349A1 WO2011105349A1 PCT/JP2011/053781 JP2011053781W WO2011105349A1 WO 2011105349 A1 WO2011105349 A1 WO 2011105349A1 JP 2011053781 W JP2011053781 W JP 2011053781W WO 2011105349 A1 WO2011105349 A1 WO 2011105349A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- crystal
- crystal form
- dimethyl
- trifluoromethoxy
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
- A01N47/06—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom containing —O—CO—O— groups; Thio analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Definitions
- the present invention relates to stable crystals of 2-ethyl-3,7-dimethyl-6- (4- (trifluoromethoxy) phenoxy) quinolin-4-ylmethyl carbonate having excellent insecticidal activity and a method for producing the same.
- the present invention also relates to an agrochemical composition comprising this stable crystal.
- crystal polymorphs When a compound forms two or more crystal states, these different crystal states are called crystal polymorphs. It is generally known that crystal polymorphism can occur in the presence of crystal polymorphs, and that the stability and physical properties of each crystal polymorph can vary. .
- This crystal polymorph transition is a phenomenon that is frequently seen in the chemical industry during drying, crushing, and storage. Defects due to crystal form transition often cause serious problems such as consolidation, crystal elongation, powdering and heat generation. In particular, in the field of agricultural chemicals, the crystal form transition phenomenon after formulation may significantly affect the agricultural chemical performance quality such as agricultural chemical efficacy and pharmaceutical storage stability. In order to avoid such problems, highly stable crystal forms have been developed.
- Patent Document 1 describes a crystalline polymorph of metazachlor, a herbicidal active ingredient. That is, a suspension composition in water using a crystalline polymorph (IA) obtained by crystallization from cyclohexane or toluene causes aggregation and is inhomogeneous and almost non-sprayable, but is a polar inert organic that is miscible with water. In the suspension composition in water using the crystalline polymorph (IB) obtained by crystallization in the presence of a solvent, no aggregation is observed and good physical properties can be maintained.
- a crystalline polymorph of metazachlor a herbicidal active ingredient. That is, a suspension composition in water using a crystalline polymorph (IA) obtained by crystallization from cyclohexane or toluene causes aggregation and is inhomogeneous and almost non-sprayable, but is a polar inert organic that is miscible with water.
- IB crystalline poly
- Patent Document 2 adverse effects such as consolidation and heat generation due to the solid phase transition of the polymorphic crystal of quizalofop-P-ethyl are avoided by obtaining a stable crystal. Furthermore, Patent Document 3 and Patent Document 4 improve the elution efficiency of tifluzamide in water by changing the crystal form of tifluzamide, which is a bactericidal active ingredient, and improve the efficacy.
- compound I 2-ethyl-3,7-dimethyl-6- (4- (trifluoromethoxy) phenoxy) quinolin-4-ylmethyl carbonate
- Patent Document 5 and Patent Document 6 2-ethyl-3,7-dimethyl-6- (4- (trifluoromethoxy) phenoxy) quinolin-4-ylmethyl carbonate
- the compound I exhibits high insecticidal activity especially against Lepidoptera, Hemiptera, Coleoptera, Mite, Hymenoptera, Diptera, Diptera, Thrips, and active ingredients of agricultural and horticultural insecticides Usefulness is expected.
- a crystal of Compound I having high physicochemical stability has not been reported so far.
- the present invention provides a crystal of Compound I that does not change in crystal characteristics due to crystal form transition under storage conditions, a method for producing a stable crystal of Compound I, and an agrochemical composition excellent in storage stability and the like. Objective.
- the present inventors dissolved the isolated product of Compound I in a solvent, and precipitated a crystal of Compound I from this solution under a temperature condition of 40 ° C. or higher, whereby a crystalline compound having stable physicochemical properties was obtained. It was found that I (hereinafter sometimes simply referred to as “B crystal form”) was obtained. The present inventors have also found that the agricultural chemical preparation using the B crystal form can remarkably suppress quality deterioration during storage such as solidification and crystal elongation of the compound I crystal and a decrease in efficacy associated therewith. The present invention is based on these findings.
- An agrochemical composition comprising the crystal according to (1) or (2) as an active ingredient.
- the crystals according to the present invention have high physicochemical stability, and can avoid the phenomenon such as crystal elongation, consolidation, and aggregation of Compound I under storage conditions in the crystalline state. Therefore, the present invention is advantageous in that it can provide a pesticidal preparation of Compound I that avoids the crystal form transition phenomenon of the active ingredient and is excellent in the stability of formulation characteristics and the stability of insecticidal efficacy in the storage state.
- FIG. 2 is a diffraction diagram of powder X-ray diffraction of Compound I in the B crystal form.
- 2 is a differential scanning calorimetry (DSC) analysis chart of the B crystal form of Compound I.
- 2 is a diffraction diagram of powder X-ray diffraction of Compound A crystal form A.
- FIG. 3 is an analysis chart of differential scanning calorimetry (DSC) of the A crystal form of Compound I. It is a microscope image photograph (1500 times) of the crystal state before storage of Example 2 (B crystal form) in Test Example 1. It is a microscope image photograph (1500 times) of the crystal state before storage of Comparative Example 1 (A crystal form) in Test Example 1. It is a microscope image photograph (1500 times) of the crystal state after storage of Example 2 (B crystal form) in Test Example 1. It is a microscope image photograph (1500 times) of the crystal state after storage of Comparative Example 1 (A crystal form) in Test Example 1.
- a peak with a relative intensity of 10% or more when the peak intensity at 2 ⁇ 21.0 ° is 100 at °, 17.1 °, 18.4 °, 20.3 °, 21.0 °, and 22.5 °.
- the B crystal form of Compound I is characterized by showing an analysis chart shown in FIG. 2 in differential scanning calorimetry (DSC). That is, the crystalline form B of Compound I has an endothermic peak at around 117.8 ° C., and has no other endothermic peak.
- a peak having a relative intensity of 10% or more when the peak intensity at 2 ⁇ 19.1 ° was set to 100 at 25.5 ° was shown.
- a diffraction peak obtained by the powder X-ray diffraction analysis includes an error range of about ⁇ 0.2 ° due to a measuring instrument, an analysis environment, and the like.
- the A crystal form of Compound I is characterized by showing the analysis chart shown in FIG. 4 in differential scanning calorimetry (DSC). That is, the A crystal form of Compound I showed an endothermic peak around 108.1 ° C., and an endothermic peak around 117.2 ° C.
- the B crystal form of Compound I according to the present invention and the A crystal form described in WO2006 / 013896 differ in the diffraction peak pattern by powder X-ray diffraction analysis and the endothermic peak pattern by differential scanning calorimetry (DSC) It is.
- the measurement results of powder X-ray diffraction of Compound I in the B crystal form and A crystal form are the results obtained by analysis under the following measurement conditions.
- the circular integration processing of the diffraction image was performed by R-AXIS Display software (manufactured by Rigaku Corporation) (integration range: 45 to 135 °).
- the relative value of each integrated intensity was calculated with the maximum value of the obtained integrated intensity as 100, and plotted against the diffraction angle 2 ⁇ to create a diffraction pattern.
- the crystal according to the present invention (B crystal form of compound I) can be prepared by precipitating the crystal of compound I from a solution of compound I under the condition of maintaining a temperature of 40 ° C. or higher. That is, a first solvent, which is a suitable soluble solvent, is added to Compound I to prepare a heated Compound I solution, and a second solvent is added to the warmed solution, and the inside of the crystallization tank is 40. By precipitating crystals while maintaining at or above C, the B crystal form of Compound I according to the present invention can be prepared.
- a first solvent which is a suitable soluble solvent
- preparation of the B crystal form of Compound I can be performed as follows. That is, Compound I is dissolved in a first solvent, and then heated to prepare Compound I warmed solution. Alternatively, a first solvent is added and dissolved with a warming operation to prepare a warmed solution of Compound I. To this, a second solvent which is arbitrarily mixed with the first solvent and whose solubility of the compound I is lower than that of the first solvent is added and mixed, so that crystals are precipitated to produce the B crystal form. be able to. In order to selectively precipitate the B crystal form, it is preferable to carry out the crystal precipitation process of Compound I under heating conditions.
- This heating condition can be set to a temperature higher than room temperature, but it is more preferable to maintain the crystallization process at a temperature of 40 ° C. or higher, and the crystallization process is controlled under a temperature condition of 45 ° C. or higher. It is preferable to do.
- the temperature control in the crystallization step when adding the second solvent to the compound I solution, it is preferable to sufficiently stir the inside of the crystallization system. As long as the desired crystallization operation is performed, the rate of addition of the second solvent to the Compound I solution, the solvent temperature, the amount of solvent, the stirring rate, and the like are not particularly limited.
- the upper temperature limit of the heating condition mentioned here can be the upper limit of the boiling point of the first solvent.
- compound I is dissolved in a heated reflux state.
- a second solvent is added to the compound I solution heated to 40 ° C. or higher in advance under stirring conditions, and the inside of the crystallization tank is at a temperature of 40 ° C. or higher.
- Maintained method a method of adding the second solvent while continuing the heating in the crystallization tank, or a second solution of the compound I solution previously heated to 40 ° C. or higher and previously heated to 40 ° C. or higher.
- a method of adding a solvent and the like can be mentioned, but the method is not particularly limited as long as the temperature is controlled at 40 ° C. or higher in the crystallization process.
- Compound I solution prepared with Compound I and the first solvent can be preheated to 40 ° C. or higher.
- a solution in which Compound I is completely dissolved under heating and refluxing in a first solvent is preferable, and a high-concentration solution of Compound I is more preferably prepared under heating and refluxing.
- Compound I is adjusted to a solution having a concentration close to saturation solubility. For example, a minimum volume of 1 to 5 volumes, preferably 1 to 2 volumes of a solvent capable of completely dissolving Compound I at the boiling point of the first solvent is added to Compound I and stirred under heating. By doing so, a heated solution can be prepared by the step of dissolving Compound I.
- the volume of the first solvent is added as the second solvent, and crystallized. Can do.
- the B crystal form of Compound I can be selectively precipitated by controlling the temperature in the crystallization tank under a temperature condition of 40 ° C. or higher.
- the crystallized suspension is stirred for several hours under heating conditions for several hours, thereby promoting crystal growth of the crystal without changing the crystal form of the B crystal form.
- the B crystal form that has undergone the heating and stirring treatment step of this crystallization suspension has good filterability and has an advantage that it is excellent in handling because it has a large bulk specific gravity and is not bulky.
- the obtained B crystal form suspension of Compound I is crystallized by a filtration method, and the obtained wet crystals are dried to obtain the B crystal form of Compound I according to the present invention.
- the drying process conditions after crystal filtration are not particularly limited, and any drying process and drying conditions can be employed. Specifically, a warming drying method, a vacuum drying method, or a warming vacuum drying method can be applied.
- the first solvent used in the present invention is not particularly limited as long as it is inert to Compound I and has a solubility.
- the soluble solvent for Compound I include alcohols, ketones, ethers, acetals, esters, nitriles, N-alkylpyrrolidones, N, N-dimethylformamide, N, N-dimethylacetamide, dimethyl sulfoxide. 1 type, or 2 or more types of mixed solvents chosen from aromatic hydrocarbons and halogenated hydrocarbons.
- the preferred solvent for obtaining the B crystal form of Compound I according to the present invention is a solvent that takes into account the solubility, crystallization process operation, and isolation process operation of Compound I. Then, alcohols are mentioned, and it is more preferable to use an alkanol in which one or more hydroxyl groups are substituted on an acyclic saturated hydrocarbon group.
- Alkanols include methanol, ethanol, 1-propanol, isopropyl alcohol, butanol, ethylene glycol, 1,3-butanediol, 1,4-butanediol, glycerin, propylene glycol, ethylene glycol diglycidyl ether, ethylene glycol monomethyl ether, ethylene Examples include glycol monoethyl ether, glycerin 1,3-dimethyl ether, diethylene glycol, diethylene glycol monoethyl ether, dipropylene glycol monomethyl ether, and 1,5-pentanediol. Particularly preferred solvents include methanol, ethanol, 1-propanol and isopropyl alcohol. These can be used alone or as a mixed solvent of two or more.
- the amount of the first solvent used can be arbitrarily set, but the solution of compound I in the first solvent is preferably a high concentration solution for the operation of the crystal precipitation step, and is a saturated solution of compound I. Is more preferable. Furthermore, the amount of the solvent in which a saturated solution of Compound I is prepared at the boiling point of the first solvent is more preferable, and the amount of the solvent in which Compound I can be completely dissolved under heating and reflux conditions is preferably used. Specifically, the amount of the first solvent used is 1 to 20 times the weight of Compound I.
- a suitable second solvent for promoting crystal crystallization used in the present invention is a solvent that is inert to Compound I, has a low solubility in Compound I, and is optional with the first solvent.
- a suitable second solvent should be selected in a mixed solubility relationship with the first solvent.
- water is an example of a suitable second solvent.
- the water may be purified water or a salt-containing aqueous solution containing an appropriate inorganic salt or organic salt.
- salts include sodium chloride, potassium chloride, calcium chloride, magnesium chloride, ammonium chloride, sodium carbonate, potassium carbonate, sodium sulfate, magnesium sulfate, sodium phosphate, potassium phosphate, and the like. In addition, it is used on condition that there is no salt precipitation when the first solvent and the second solvent are mixed.
- the amount of the second solvent used may be any amount that causes compound I to crystallize from the compound I solution.
- the second solvent can be used in an amount of 0.1 to 10 times, preferably 0.3 to 3 times the volume of the first solvent.
- the A crystal form of Compound I can be synthesized and isolated according to the quinoline derivative synthesis method described in International Publication No. WO2006 / 013896 pamphlet.
- the crystal form of compound I isolated by the compound I synthesis reaction is dissolved in a dimethylacetamide solvent at room temperature, and the compound I solution is put into water adjusted to room temperature or lower such as ice water, and the crystal of compound I is obtained. Crystallize. By isolating it by filtration, the A crystal form of Compound I can be selectively prepared.
- the B crystal form of Compound I in the present invention has high physicochemical stability, and does not cause phenomena such as crystal elongation, consolidation and aggregation under storage conditions in the crystalline state. Therefore, since the agrochemical composition containing the crystalline form B of Compound I as an active ingredient is free from the crystal form transition phenomenon of the active ingredient, it is excellent in the stability of pharmaceutical properties in a stored state and excellent in maintaining stable insecticidal efficacy. It is.
- the formulation form of the agrochemical composition using the B crystal form of Compound I as an active ingredient there are no particular limitations on the formulation form of the agrochemical composition using the B crystal form of Compound I as an active ingredient, but in the case of a formulation form in which the active ingredient crystal is maintained during the formulation, the B crystal form of Compound I
- a dosage form is a preferred pharmaceutical dosage form because of its advantageous pharmaceutical effects due to its physicochemical properties.
- powders, wettable powders, granular wettable powders, granules, suspensions in water and the like can be mentioned as suitable dosage forms. Each of these can be prepared according to a general formulation.
- the additive other than the B crystal form of Compound I added to the agrochemical composition of the present invention is not particularly limited as long as it does not impair the stability of Compound I.
- the solid carrier, surfactant, Other formulation adjuvants can be used.
- the crystalline form B of Compound I can be mixed with a solid carrier and other additives as required, and prepared into powders, wettable powders, wettable granules and granules by conventional methods. Further, the crystalline form B of Compound I can be prepared as a suspension in water by a conventional method by mixing with a surfactant and a solvent (for example, water) and other additives as required.
- a surfactant for example, water
- solid carriers examples include talc, bentonite, clay, kaolin, diatomaceous earth, vermiculite, white carbon, calcium carbonate, acid clay, silica sand, silica, zeolite, attapulgite, pumice, ammonium sulfate, sodium sulfate, urea, potassium chloride, sodium chloride, Examples thereof include crystalline cellulose, carboxymethyl cellulose, xanthan gum and the like.
- Nonionic surfactants used in the present invention include polyoxyethylene alkyl ether, polyoxyethylene styryl phenyl ether, polyoxyethylene alkyl ester, polyoxyethylene phenyl ether polymer, polyoxyethylene alkylene aryl phenyl ether, polyoxyethylene poly Examples include an oxypropylene block polymer, polyoxyethylenated castor oil, polyoxyethylenated hydrogenated castor oil, glyceryl monostearate, and glyceryl distearate.
- Anionic surfactants include polyoxyethylene styryl phenyl ether sulfate and lignin.
- Sulfonate, alkylaryl sulfonate, alkylnaphthalene sulfonate, polycarboxylate, polyoxyethylene polystyryl Vinyl ether include anionic surfactants such as sulfates and phosphates, but not limited to this as long as they do not impair the stability of the agrochemical active ingredient.
- anionic surfactants such as sulfates and phosphates, but not limited to this as long as they do not impair the stability of the agrochemical active ingredient.
- one or more selected from the group of these nonionic and anionic surfactants can be used in combination.
- examples of other adjuvants for preparations include anti-settling agents and anti-freezing agents.
- examples of the anti-settling agent include bentonite, smectite, xanthan gum, crystalline cellulose, carboxymethyl cellulose and the like, but are not limited thereto, and one or more selected from these can be used in combination.
- antifreezing agent examples include, but are not limited to, ethylene glycol, propylene glycol, glycerin, diethylene glycol, polyethylene glycol and the like. One or more selected from these can be used in combination.
- the agrochemical composition of the present invention can be mixed or used in combination with other insecticides, fungicides, acaricides, herbicides, plant growth regulators, fertilizers and the like.
- examples of drugs that can be mixed or used together are described in, for example, the Pesticide Manual (published by The 13th Edition The British Crop Protection Council) and Shibuya Index (SHIBUA INDEX 14th Edition, 2009, published by SHIBUYA INDEX RESEARCH GROUP) Can be mentioned.
- insecticide is, for example, acephate, dichlorvos, EPN, fenitrotorion, fenamifos, prothiofos, profenofos, pyraclofos, chlorpyrifos.
- Organophosphate compounds such as chlorpyrifos-methyl and diazinon; methomyl, thiodicarb, aldicarb, oxamyl, propoxur, carbaryl Carbamate compounds such as fenobucarb, fenobucarb, ethiofencarb, fenothiocarb, pirimicarb, carbofuran, benfuracarb; cartap, chi Nereistoxin derivatives such as thiocyclam; organochlorine compounds such as dicofol and tetradifon; permethrin, tefluthrin, cypermethrin, deltamethrin, Pyrethroid compounds such as cyhalothrin, fenvalerate, fluvalinate, etofenprox, silafluofen; diflubenzuron, teflubenzuron, flufenoxuron ), A benzoylurea compound such as chlorfluazu
- insecticides include buprofezin, hexythiazox, chlordimeform, pyridaben, amitraz, fenpyroxymate, pyrimidifen, tebufenpyrad tebufenpyrad fluacrypyrim, acequinocyl, fipronyl, ethoxazole, imidacloprid, clothianidin, pymetrozine, bifenazate, spirodiclofen, spirodiclofen, spirodiclofen Pyriproxyfen, indoxacarb, pyridalyl, spinosad, avermectin, mi Examples include milbemycin, organometallic compounds, and dinitro compounds. Furthermore, the agricultural and horticultural insecticide according to the present invention can be used in combination with or in combination with microbial pesticides such as BT agents and entomopathogenic virus agents.
- fungicides used are, for example, strobilurin compounds such as azoxystrobin, cresoxym-methyl, trifloxystrobin; mepanipyrim, pyrimethanil, cyprodinil Anilinopyrimidine compounds such as triadimefon, bitertanol, triflumizole, etaconazole, propiconazole, penconazole, flusilazole, microbutanil ), Cyproconazole, tebuconazole, hexaconazole, prochlaroz, azole compounds such as simeconazole; quinome Quinoxaline compounds such as quinomethionate; dithiocarbamate compounds such as maneb, zineb, mancozeb, polycarbamate, and puropineb; like dietophencarb Phenyl carbamate compounds; organochlorine compounds such as chlorothalonil and quintozene; benzimidazole compounds such as benomy
- fungicides include fthalide, fluazinam, cymoxanil, triforine, pyrifenox, fenarimol, fenpropidin, pencicuron. , Cyazofamid, iprovalicarb, benchthiavalicarb-isopropyl and the like.
- the agrochemical composition using the B crystal form of Compound I obtained by the present invention as an active ingredient has improved storage stability compared with the case of using the A crystal form, the crystal elongation is remarkably suppressed, and accompanied by crystal elongation. It has the advantage that no decrease in efficacy or consolidation of the agricultural chemical composition is observed.
- the circular integration processing of the diffraction image was performed by R-AXIS Display software (manufactured by Rigaku Corporation) (integration range: 45 to 135 °).
- the relative value of each integrated intensity was calculated with the maximum value of the obtained integrated intensity as 100, and plotted against the diffraction angle 2 ⁇ to create a diffraction pattern.
- the powder X-ray diffraction pattern of the resulting compound I (A crystal form) is shown in FIG.
- FIG. 4 shows an analysis chart of differential scanning calorimetry (DSC) of the obtained compound I (A crystal form).
- DSC differential scanning calorimetry
- Example 1 Preparation of Compound I in Form B of Compound I
- a 3000 mL flask equipped with a stirrer, condenser, dropping funnel, and thermometer 148.8 g of Form I of Compound I obtained by Reference Example, and 1200 mL of methanol was added.
- the mixed solution was heated to reflux to completely dissolve the crystals, and then 520 mL of distilled water was dropped into the solution at an internal temperature of 40 to 65 ° C. to cause crystal crystallization.
- the internal temperature of the mixed solution was maintained at 40 to 65 ° C.
- the suspension was further heated to reflux for 2 hours.
- the powder X-ray diffraction pattern of the obtained Compound I in the B crystal form is shown in FIG.
- 2 ⁇ 5.30 °, 6.86 °, 8.51 °, 9.98 °, 10.28 °, 11.32 °, 20.
- FIG. 2 shows an analysis chart of differential scanning calorimetry (DSC) of the B crystal form of Compound I obtained.
- DSC differential scanning calorimetry
- Example 2 Preparation of Compound I containing a crystalline form of B (suspension in water) B crystalline form of Compound I obtained in Example 1 10.8 parts by weight, Neukalgen FS-3PG (trade name, surfactant) Agent, manufactured by Takemoto Yushi Co., Ltd.) 1.0 part by weight, Demol N (trade name, surfactant, manufactured by Kao Corporation) 1.0 part by weight, Antihome E-20 (trade name, defoamer, manufactured by Kao Corporation) 0.1 parts by weight and 30 parts by weight of water were mixed and pulverized with a Imex type vertical wet pulverizer (1000 rpm, 90 minutes).
- Neukalgen FS-3PG trade name, surfactant
- Demol N trade name, surfactant, manufactured by Kao Corporation
- Antihome E-20 trade name, defoamer, manufactured by Kao Corporation
- Xanthan gum 0.2 parts by weight, Kunipia F (trade name, thickener, manufactured by Kunimine Kogyo Co., Ltd.) 0.3 parts by weight, propylene glycol 7.5 parts by weight, Proxel GXL (S) (trade name, prevention In addition to a mixture of 0.2 parts by weight (manufactured by Arch Chemicals Japan Co., Ltd.) and 49.1 parts by weight of water, a suspension in water (flowable preparation) containing 10.8% by weight of the crystalline form B of Compound I is obtained. It was.
- Example 3 Preparation of a preparation containing B crystal form of Compound I (wettable powder) B crystal form of Compound I obtained in Example 1 10.5 parts by weight, Carplex # 80 (trade name, white carbon, Degussa Japan)) 10.0 parts by weight, lactose 73.5 parts by weight, New Calgen BX-C (trade name, surfactant, Takemoto Yushi Co., Ltd.) 3.0 parts by weight, New Calgen WG-4 (trade name, Surfactant (manufactured by Takemoto Yushi Co., Ltd.) (3.0 parts by weight) was mixed and pulverized by a sample mill to obtain a wettable powder containing 10.5% by weight of Compound I in B crystal form.
- Carplex # 80 trade name, white carbon, Degussa Japan
- New Calgen BX-C trade name, surfactant, Takemoto Yushi Co., Ltd.
- New Calgen WG-4 trade name, Surfactant (manufactured by Takemoto
- Comparative Example 1 Preparation of Compound I A Crystal Form-Containing Formulation (Suspension in Water) Compound I A Crystal Form 10.8 parts by weight, Neucargen FS-3PG (trade name, surfactant, Takemoto Yushi Co., Ltd.) 1.0 part by weight, Demol N (trade name, surfactant, manufactured by Kao Corporation) 1.0 part by weight, Antihome E-20 (trade name, defoaming agent, manufactured by Kao Corporation) 0.1 part by weight, water 30 parts by weight were mixed, and pulverized with an Imex vertical pulverizer (1000 rpm, 90 minutes).
- Neucargen FS-3PG trade name, surfactant, Takemoto Yushi Co., Ltd.
- Demol N trade name, surfactant, manufactured by Kao Corporation
- Antihome E-20 trade name, defoaming agent, manufactured by Kao Corporation
- Xanthan gum 0.2 parts by weight, Kunipia F (trade name, thickener, manufactured by Kunimine Kogyo Co., Ltd.) 0.3 parts by weight, propylene glycol 7.5 parts by weight, Proxel GXL (S) (trade name, prevention In addition to a mixture of 0.2 parts by weight (manufactured by Arch Chemicals Japan) and 49.1 parts by weight of water, a suspension in water (flowable preparation) containing 10.8% by weight of crystalline form A of Compound I is obtained. It was.
- Test Example 1 Storage Test The suspensions in water of Example 2 and Comparative Example 1 were stored at 54 ° C. for 2 weeks, and the change in quality before and after storage was observed. The crystal size before and after the storage test was measured with a laser diffraction particle size analyzer and with an optical microscope.
- Example 2 shows no change in the properties in the preparation.
- the fluidity was maintained as a suspension in water.
- the particle size before and after the storage test of the preparation of Example 2 hardly changed by any of the measurement methods, and according to the microscopic images of the particle state (see FIG. 5 and FIG. 7), the growth of crystal particles was clearly suppressed. It was.
- the preparation of Comparative Example 1 is solidified after storage test and loses its fluidity as a suspension in water, is difficult to dilute with water, and can be applied as an agricultural and horticultural insecticide. It was difficult.
- the B crystal form of Compound I according to the present invention has high physicochemical stability and excellent storage stability, it can be preserved by adopting the B crystal form of Compound I as the active ingredient of an agrochemical active ingredient.
- An agrochemical formulation with excellent stability can be provided.
- Test Example 2 Efficacy Confirmation Test
- the aqueous suspension preparations of Example 2 and Comparative Example 1 were stored at 54 ° C. for 2 weeks. A dilute water solution having a predetermined concentration was prepared and 2 mL was sprayed onto a cucumber leaf disk. After air drying, about 25 to 40 adult tobacco whitefly were released, covered with absorbent cotton and placed upside down. Two days after the treatment, the number of dead insects was counted to calculate an LC50 value (ppm). The particle diameter was measured according to the laser diffraction particle size distribution measuring instrument and procedure described in Test Example 1.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Quinoline Compounds (AREA)
Abstract
Description
回折角(2θ)
5.3±0.2°
6.9±0.2°
8.5±0.2°
10.0±0.2°
10.3±0.2°
11.3±0.2°
20.3±0.2°
21.0±0.2°
に回折ピークを有する2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネートの結晶。
回折角(2θ)
12.2±0.2°
16.6±0.2°
17.1±0.2°
18.4±0.2°
22.5±0.2°
に回折ピークを有する、前記(1)に記載の2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネートの結晶。
参考例および実施例1の粉末X線回折測定の分析機器および測定条件を以下に示した。A結晶形のX線回折データの測定は、イメージングプレート型X線回折装置(理学電機社製 R-AXIS VII)を使用し、Cu-Kα放射線(50kV、100mA、λ=1.5418Å)を用いて実施した。具体的には、サンプルを内径0.7mmのガラス製キャピラリーに充填し、カメラ長300mm、振動角45°間隔、露光時間90分の条件で合計6枚の回折像を撮影し、データを収集した。
攪拌装置、温度計、還流冷却器、塩化カルシウム管を備えた容量2000mLのガラス製フラスコに、窒素雰囲気下、ジメチルホルムアミド980mL、WO2006/013896号公報に記載の方法に準じて合成した2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4(1H)-オン 98gを仕込み、15℃に冷却した。55%水素化ナトリウム18.2gを滴下し、室温にて1時間反応した。クロロ蟻酸メチル32.1gを滴下し、室温にて1時間反応した。この反応混合物を10Lプラスチック容器中の氷水5Lに注ぎ、室温にて2時間攪拌した。析出した固体を吸引濾過器にて濾過し、n-ヘキサンと水で洗浄した。固体を減圧乾燥し、化合物I(2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネート)(A結晶形) 103.3g(収率91.4%)を得た。得られた生成物は以下のスペクトルデータから、化合物Iであることを同定した。
1H-NMR(CDCl3) 1.38(t,3H),2.31(s,3H),2.41(s,3H),3.01(q,2H),3.88(s,3H),6.97(d,2H),7.14(s,1H),7.20(d,2H),7.94(s,1H)
攪拌装置、冷却管、滴下漏斗、および温度計を備え付けた3000mL四径フラスコに、参考例によって得られた化合物IのA結晶形148.8g、および1200mLのメタノールを加えた。この混合液を加熱還流して結晶を完全に溶解させた後、溶液中に内温40~65℃の温度範囲において、蒸留水520mLを滴下して結晶晶析させた。なお、混合溶液の内温は40~65℃に維持した。さらにこの懸濁液を2時間加熱還流した。懸濁液を冷却後、結晶を濾別し、410mLの50%(v/v)メタノール水で洗浄し、60℃で減圧乾燥することで140.6gの化合物IのB結晶形を得た。得られた生成物は以下に示すスペクトルデータから化合物Iであると同定した。
1H-NMR(CDCl3) 1.38(t,3H),2.31(s,3H),2.41(s,3H),3.01(q,2H),3.88(s,3H),6.97(d,2H),7.14(s,1H),7.20(d,2H),7.94(s,1H)
実施例1により得られた化合物IのB結晶形 10.8重量部、ニューカルゲンFS-3PG(商品名、界面活性剤、竹本油脂社製)1.0重量部、デモールN(商品名、界面活性剤、花王社製)1.0重量部、アンチホームE-20(商品名、消泡剤、花王社製)0.1重量部、水30重量部を混合し、アイメックス社製竪型湿式粉砕機(1000rpm、90分)にて粉砕した。この粉砕物をキサンタンガム 0.2重量部、クニピアF(商品名、増粘剤、クニミネ工業社製) 0.3重量部、プロピレングリコール 7.5重量部、プロクセルGXL(S)(商品名、防黴剤、アーチケミカルズ・ジャパン社製)0.2重量部、水49.1重量部の混合物に加えて化合物IのB結晶形10.8重量%を含む水中懸濁製剤(フロアブル製剤)を得た。
実施例1により得られた化合物IのB結晶形 10.5重量部、カープレックス#80(商品名、ホワイトカーボン、デグサジャパン社製)10.0重量部、乳糖 73.5重量部、ニューカルゲンBX-C(商品名、界面活性剤、竹本油脂社製)3.0重量部、ニューカルゲンWG-4(商品名、界面活性剤、竹本油脂社製)3.0重量部を混合してサンプルミルにて粉砕し、化合物IのB結晶形10.5重量%を含む水和剤を得た。
化合物IのA結晶形 10.8重量部、ニューカルゲンFS-3PG(商品名、界面活性剤、竹本油脂社製)1.0重量部、デモールN(商品名、界面活性剤、花王社製)1.0重量部、アンチホームE-20(商品名、消泡剤、花王社製)0.1重量部、水30重量部を混合し、アイメックス社製竪型湿式粉砕機(1000rpm、90分)にて粉砕した。この粉砕物をキサンタンガム 0.2重量部、クニピアF(商品名、増粘剤、クニミネ工業社製) 0.3重量部、プロピレングリコール 7.5重量部、プロクセルGXL(S)(商品名、防黴剤、アーチケミカルズ・ジャパン社製)0.2重量部、水49.1重量部の混合物に加えて化合物IのA結晶形 10.8重量%を含む水中懸濁製剤(フロアブル製剤)を得た。
実施例2および比較例1の水中懸濁製剤を54℃にて2週間保存し、保存の前後における品質の変化を観察した。保存試験前後の結晶の大きさは、レーザー回折粒度分布測定器による測定と光学顕微鏡による測定を行った。
使用機器:島津社製レーザー回折粒度分布測定器SALD-2200
水で希釈した保存試験後のフロアブル製剤を上記測定器にて粒度測定に供した。なお、保存後のA結晶形は水に懸濁しなかったため、粗い粒核がなくなるまで超音波を照射したものを測定に供した。
使用機器:キーエンス社製デジタルマイクロスコープVHX-200
水で希釈した保存試験後のフロアブル製剤を上記機器にて1500倍に拡大して撮影した。画像中の結晶の長径を測定し、その平均値を算出した。なお、保存後のA結晶形は水に懸濁しなかったため、粗い粒核がなくなるまで超音波を照射したものを測定に供した。
実施例2および比較例1の水性懸濁製剤を54℃で2週間保存した。これを所定濃度の水希釈液を調製し、キュウリのリーフディスクに2mL散布した。風乾後、タバココナジラミ成虫を約25~40頭放虫し、脱脂綿で蓋をして逆さまに置いた。処理2日後に死亡虫数を数えてLC50値(ppm)を算出した。粒子径の測定は試験例1に記載されたレーザー回折粒度分布測定器と手順に従って行った。
Claims (7)
- 粉末X線回折において、少なくとも下記回折角(2θ):
回折角(2θ)
5.3±0.2°
6.9±0.2°
8.5±0.2°
10.0±0.2°
10.3±0.2°
11.3±0.2°
20.3±0.2°
21.0±0.2°
に回折ピークを有する2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネートの結晶。 - 粉末X線回折において、更に下記回折角(2θ):
回折角(2θ)
12.2±0.2°
16.6±0.2°
17.1±0.2°
18.4±0.2°
22.5±0.2°
に回折ピークを有する、請求項1に記載の2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネートの結晶。 - 2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネートのアルカノール溶液から、40℃以上の温度条件で、結晶を析出させることを含んでなる、請求項1または2に記載の結晶を製造する方法。
- 2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネートのアルカノール溶液に水を添加し、40℃以上の温度条件で結晶を析出させることを含んでなる、請求項1または2に記載の結晶を製造する方法。
- 請求項1または2に記載の結晶を有効成分として含んでなる農薬組成物。
- 界面活性剤および水を更に含んでなる、請求項5に記載の農薬組成物。
- 界面活性剤および固体担体を更に含んでなる、請求項5に記載の農薬組成物。
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2011218939A AU2011218939B2 (en) | 2010-02-23 | 2011-02-22 | Stable crystal form of 2-ethyl-3,7-dimethyl- 6-(4-(trifluoromethoxy) phenoxy) quinoline -4-ylmethyl carbonate, method of manufacturing same and agricultural chemical composition containing crystals of same |
CN201180020111.3A CN102884050B (zh) | 2010-02-23 | 2011-02-22 | 2-乙基-3,7-二甲基-6-(4-(三氟甲氧基)苯氧基)喹啉-4-基甲基碳酸酯的稳定晶体、其制备方法以及包含该晶体的农用化学组合物 |
KR1020127024395A KR101814836B1 (ko) | 2010-02-23 | 2011-02-22 | 2-에틸-3,7-디메틸-6-(4-(트리플루오로메톡시)페녹시)퀴놀린-4-일 메틸 카보네이트의 안정형 결정, 그것의 제조방법 및 그것의 결정을 함유하는 농약 조성물 |
JP2012501777A JP5697655B2 (ja) | 2010-02-23 | 2011-02-22 | 2−エチル−3,7−ジメチル−6−(4−(トリフルオロメトキシ)フェノキシ)キノリン−4−イルメチルカーボネートの安定型結晶およびその製造方法並びにその結晶を含有する農薬組成物 |
RU2012140431/04A RU2545094C2 (ru) | 2010-02-23 | 2011-02-22 | Стабильная кристаллическая форма 2-этил-3,7-диметил-6-(трифторметокси)фенокси)хинолин-4-илметилкарбоната, способ ее получения и агрохимическая композиция, содержащая данную кристаллическую форму |
EP11747310.8A EP2540709B1 (en) | 2010-02-23 | 2011-02-22 | Stable crystal form of 2-ethyl-3, 7-dimethyl-6-(4-(trifluoromethoxy) phenoxy)quinoline-4-ylmethyl carbonate, method of manufacturing same and agricultural chemical composition containing crystals of same |
ES11747310.8T ES2523758T3 (es) | 2010-02-23 | 2011-02-22 | Forma cristalina estable de carbonato de 2-etil-3,7-dimetil-6-(4-(trifluorometoxi)fenoxi)quinolin-4-il-metilo, método de producción de la misma, y composición química agrícola que contiene cristales de la misma |
CA2790921A CA2790921A1 (en) | 2010-02-23 | 2011-02-22 | Stabilized crystal of 2-ethyl-3,7-dimethyl-6-(4-(trifluoromethoxy)phenoxy)quinoline-4-yl methyl carbonate, process for producing the crystal, and agricultural chemical compositioncomprising the crystal |
US13/580,550 US8648195B2 (en) | 2010-02-23 | 2011-02-22 | Stabilized crystal of 2-ethyl-3,7-dimethyl-6-(4-(trifluoromethoxy)phenoxy)quinoline-4-yl methyl carbonate, process for producing the crystal, and agricultural chemical composition comprising the crystal |
BR112012021146A BR112012021146A8 (pt) | 2010-02-23 | 2011-02-22 | cristal estabilizado de 2-etil-3,7-dimetil-6-(4-(trifluormetoxi) fenoxi) quinolina-4-il metil carbonato, processo para produção do cristal, e composição química agrícola constituída pelo cristal. |
SG2012062287A SG183453A1 (en) | 2010-02-23 | 2011-02-22 | Stabilized crystal of 2-ethyl-3, 7-dimethyl-6-(4-(trifluoromethoxy) phenoxy)quinoline-4-ylmethyl carbonate, process for producing the crystal, and agricultural chemical composition comprising the crystal |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010037475 | 2010-02-23 | ||
JP2010-037475 | 2010-02-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011105349A1 true WO2011105349A1 (ja) | 2011-09-01 |
Family
ID=44506757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2011/053781 WO2011105349A1 (ja) | 2010-02-23 | 2011-02-22 | 2-エチル-3,7-ジメチル-6-(4-(トリフルオロメトキシ)フェノキシ)キノリン-4-イルメチルカーボネートの安定型結晶およびその製造方法並びにその結晶を含有する農薬組成物 |
Country Status (13)
Country | Link |
---|---|
US (1) | US8648195B2 (ja) |
EP (1) | EP2540709B1 (ja) |
JP (1) | JP5697655B2 (ja) |
KR (1) | KR101814836B1 (ja) |
CN (1) | CN102884050B (ja) |
AU (1) | AU2011218939B2 (ja) |
BR (1) | BR112012021146A8 (ja) |
CA (1) | CA2790921A1 (ja) |
ES (1) | ES2523758T3 (ja) |
RU (1) | RU2545094C2 (ja) |
SG (1) | SG183453A1 (ja) |
TW (1) | TWI491356B (ja) |
WO (1) | WO2011105349A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013122241A1 (en) * | 2012-02-16 | 2013-08-22 | Sumitomo Chemical Company, Limited | Crystal of flumioxazin |
WO2014119620A1 (ja) * | 2013-01-30 | 2014-08-07 | Meiji Seikaファルマ株式会社 | 水性懸濁状農薬組成物 |
JP2015506968A (ja) * | 2012-02-09 | 2015-03-05 | シンジェンタ リミテッド | N−(2−メトキシベンゾイル)−4−[(メチルアミノカルボニル)アミノ]ベンゼンスルホンアミドの多形体 |
JP2017512201A (ja) * | 2014-02-27 | 2017-05-18 | シンジェンタ パーティシペーションズ アーゲー | 3−ジフルオロメチル−1―メチル−1h−ピラゾール−4−カルボン酸(9−ジクロロメチレン−1,2,3,4−テトラヒドロ−1,4−メタノ−ナフタレン−5−イル)−アミドの多形 |
WO2019235602A1 (ja) * | 2018-06-08 | 2019-12-12 | 日本化薬株式会社 | 水和性農薬組成物 |
US11267787B2 (en) | 2017-12-12 | 2022-03-08 | Nippon Kayaku Co., Ltd | Method for producing quinolin-4(1H)-one derivative |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103814939A (zh) * | 2014-02-21 | 2014-05-28 | 深圳诺普信农化股份有限公司 | 一种杀虫组合物 |
CN113875766B (zh) * | 2020-07-02 | 2023-09-15 | 江苏龙灯化学有限公司 | 一种杀虫组合物 |
CN111808020B (zh) * | 2020-09-07 | 2020-12-01 | 湖南速博生物技术有限公司 | 一种flometoquin中间体的合成方法 |
CN115500354B (zh) * | 2022-10-26 | 2024-03-01 | 海利尔药业集团股份有限公司 | 一种杀虫组合物及其用途 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0366671A (ja) | 1989-07-29 | 1991-03-22 | Basf Ag | 単斜晶系メタザクロルならびにその製造方法及びこれを含有する除草剤 |
JPH09502169A (ja) * | 1993-08-19 | 1997-03-04 | メルク エンド カンパニー インコーポレーテッド | 熱力学的に安定な結晶形の4″−デオキシ−4″−エピ−メチルアミノアベルメクチンB1a/B1bの安息香酸塩及びその製造法 |
JPH09227538A (ja) | 1996-02-28 | 1997-09-02 | Nissan Chem Ind Ltd | 効力が安定化したチフルザミド |
JPH101476A (ja) | 1996-02-28 | 1998-01-06 | Nissan Chem Ind Ltd | 効力が向上したチフルザミド |
JP2001114707A (ja) | 1999-10-14 | 2001-04-24 | Nissan Chem Ind Ltd | 安定型結晶を製造する方法 |
JP2005112738A (ja) * | 2003-10-03 | 2005-04-28 | Nissan Chem Ind Ltd | 結晶多形インド−ル化合物およびその製造方法 |
WO2006013896A1 (ja) | 2004-08-04 | 2006-02-09 | Meiji Seika Kaisha, Ltd. | キノリン誘導体およびそれを有効成分として含んでなる殺虫剤 |
WO2008020532A1 (en) * | 2006-08-15 | 2008-02-21 | Cosmo Oil Co., Ltd. | Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
WO2008093325A2 (en) * | 2007-02-01 | 2008-08-07 | Makhteshim Chemical Works Ltd. | Polymorphs of 3-(e)-2-{2-[6-(2-cyanophenoxy) pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate |
WO2008113447A2 (en) * | 2007-03-16 | 2008-09-25 | Syngenta Limited | Novel solid forms of a microbiocide |
WO2010007964A1 (ja) | 2008-07-15 | 2010-01-21 | 日本化薬株式会社 | 6-アリールオキシキノリン誘導体の製造方法およびその中間体 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6486195B1 (en) | 1993-08-19 | 2002-11-26 | Merck & Co., Inc. | Thermodynamically stable crystal form of 4″-deoxy-4″-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation |
KR100343834B1 (ko) * | 1994-08-04 | 2003-01-24 | 스미또모 가가꾸 고오교오 가부시끼가이샤 | 디할로프로펜화합물,그를함유한살충제/살비제및그제조용중간산물 |
WO2007088978A1 (ja) * | 2006-02-03 | 2007-08-09 | Meiji Seika Kaisha, Ltd. | 新規キノリン誘導体およびこれを有効成分として含有する農園芸用殺菌剤 |
-
2011
- 2011-02-22 US US13/580,550 patent/US8648195B2/en active Active
- 2011-02-22 CA CA2790921A patent/CA2790921A1/en not_active Abandoned
- 2011-02-22 AU AU2011218939A patent/AU2011218939B2/en active Active
- 2011-02-22 EP EP11747310.8A patent/EP2540709B1/en not_active Not-in-force
- 2011-02-22 ES ES11747310.8T patent/ES2523758T3/es active Active
- 2011-02-22 KR KR1020127024395A patent/KR101814836B1/ko active IP Right Grant
- 2011-02-22 TW TW100105786A patent/TWI491356B/zh active
- 2011-02-22 WO PCT/JP2011/053781 patent/WO2011105349A1/ja active Application Filing
- 2011-02-22 CN CN201180020111.3A patent/CN102884050B/zh active Active
- 2011-02-22 JP JP2012501777A patent/JP5697655B2/ja active Active
- 2011-02-22 SG SG2012062287A patent/SG183453A1/en unknown
- 2011-02-22 BR BR112012021146A patent/BR112012021146A8/pt not_active Application Discontinuation
- 2011-02-22 RU RU2012140431/04A patent/RU2545094C2/ru not_active IP Right Cessation
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0366671A (ja) | 1989-07-29 | 1991-03-22 | Basf Ag | 単斜晶系メタザクロルならびにその製造方法及びこれを含有する除草剤 |
JPH09502169A (ja) * | 1993-08-19 | 1997-03-04 | メルク エンド カンパニー インコーポレーテッド | 熱力学的に安定な結晶形の4″−デオキシ−4″−エピ−メチルアミノアベルメクチンB1a/B1bの安息香酸塩及びその製造法 |
JPH09227538A (ja) | 1996-02-28 | 1997-09-02 | Nissan Chem Ind Ltd | 効力が安定化したチフルザミド |
JPH101476A (ja) | 1996-02-28 | 1998-01-06 | Nissan Chem Ind Ltd | 効力が向上したチフルザミド |
JP2001114707A (ja) | 1999-10-14 | 2001-04-24 | Nissan Chem Ind Ltd | 安定型結晶を製造する方法 |
JP2005112738A (ja) * | 2003-10-03 | 2005-04-28 | Nissan Chem Ind Ltd | 結晶多形インド−ル化合物およびその製造方法 |
WO2006013896A1 (ja) | 2004-08-04 | 2006-02-09 | Meiji Seika Kaisha, Ltd. | キノリン誘導体およびそれを有効成分として含んでなる殺虫剤 |
WO2008020532A1 (en) * | 2006-08-15 | 2008-02-21 | Cosmo Oil Co., Ltd. | Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
WO2008093325A2 (en) * | 2007-02-01 | 2008-08-07 | Makhteshim Chemical Works Ltd. | Polymorphs of 3-(e)-2-{2-[6-(2-cyanophenoxy) pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate |
WO2008113447A2 (en) * | 2007-03-16 | 2008-09-25 | Syngenta Limited | Novel solid forms of a microbiocide |
WO2010007964A1 (ja) | 2008-07-15 | 2010-01-21 | 日本化薬株式会社 | 6-アリールオキシキノリン誘導体の製造方法およびその中間体 |
Non-Patent Citations (2)
Title |
---|
"The Pesticide Manual", 2009, SHIBUYA INDEX RESEARCH GROUP |
See also references of EP2540709A4 |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015506968A (ja) * | 2012-02-09 | 2015-03-05 | シンジェンタ リミテッド | N−(2−メトキシベンゾイル)−4−[(メチルアミノカルボニル)アミノ]ベンゼンスルホンアミドの多形体 |
WO2013122241A1 (en) * | 2012-02-16 | 2013-08-22 | Sumitomo Chemical Company, Limited | Crystal of flumioxazin |
WO2014119620A1 (ja) * | 2013-01-30 | 2014-08-07 | Meiji Seikaファルマ株式会社 | 水性懸濁状農薬組成物 |
KR20150126596A (ko) * | 2013-01-30 | 2015-11-12 | 메이지 세이카 파루마 가부시키가이샤 | 수성 현탁상 농약 조성물 |
US9485987B2 (en) | 2013-01-30 | 2016-11-08 | Meiji Seika Pharma Co., Ltd. | Aqueous suspended agricultural chemical composition |
JPWO2014119620A1 (ja) * | 2013-01-30 | 2017-01-26 | Meiji Seikaファルマ株式会社 | 水性懸濁状農薬組成物 |
KR102055969B1 (ko) | 2013-01-30 | 2019-12-13 | 메이지 세이카 파루마 가부시키가이샤 | 수성 현탁상 농약 조성물 |
JP2017512201A (ja) * | 2014-02-27 | 2017-05-18 | シンジェンタ パーティシペーションズ アーゲー | 3−ジフルオロメチル−1―メチル−1h−ピラゾール−4−カルボン酸(9−ジクロロメチレン−1,2,3,4−テトラヒドロ−1,4−メタノ−ナフタレン−5−イル)−アミドの多形 |
US11267787B2 (en) | 2017-12-12 | 2022-03-08 | Nippon Kayaku Co., Ltd | Method for producing quinolin-4(1H)-one derivative |
WO2019235602A1 (ja) * | 2018-06-08 | 2019-12-12 | 日本化薬株式会社 | 水和性農薬組成物 |
JPWO2019235602A1 (ja) * | 2018-06-08 | 2021-06-17 | 日本化薬株式会社 | 水和性農薬組成物 |
US11547115B2 (en) | 2018-06-08 | 2023-01-10 | Nippon Kayuku Co., Ltd. | Wettable agrochemical composition |
Also Published As
Publication number | Publication date |
---|---|
CN102884050B (zh) | 2014-05-28 |
US8648195B2 (en) | 2014-02-11 |
JP5697655B2 (ja) | 2015-04-08 |
AU2011218939A1 (en) | 2012-10-04 |
JPWO2011105349A1 (ja) | 2013-06-20 |
CN102884050A (zh) | 2013-01-16 |
TW201204255A (en) | 2012-02-01 |
EP2540709A1 (en) | 2013-01-02 |
US20130045989A1 (en) | 2013-02-21 |
CA2790921A1 (en) | 2011-09-01 |
SG183453A1 (en) | 2012-09-27 |
RU2012140431A (ru) | 2014-03-27 |
EP2540709A4 (en) | 2013-07-31 |
RU2545094C2 (ru) | 2015-03-27 |
BR112012021146A8 (pt) | 2017-02-07 |
KR101814836B1 (ko) | 2018-01-04 |
TWI491356B (zh) | 2015-07-11 |
AU2011218939B2 (en) | 2015-08-13 |
ES2523758T3 (es) | 2014-12-01 |
KR20130056213A (ko) | 2013-05-29 |
BR112012021146A2 (pt) | 2015-09-22 |
EP2540709B1 (en) | 2014-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5697655B2 (ja) | 2−エチル−3,7−ジメチル−6−(4−(トリフルオロメトキシ)フェノキシ)キノリン−4−イルメチルカーボネートの安定型結晶およびその製造方法並びにその結晶を含有する農薬組成物 | |
JP5015203B2 (ja) | キノリン誘導体およびそれを有効成分として含んでなる殺虫剤 | |
JP5112083B2 (ja) | 新規キノリン誘導体およびこれを有効成分として含有する農園芸用殺菌剤 | |
JP2008110953A (ja) | キノリン誘導体およびそれを含んでなる農園芸用殺虫剤 | |
TW200803735A (en) | Cyclic amine compounds and agents for pest control | |
JP2013166724A (ja) | フルミオキサジンの結晶形 | |
WO2015169883A1 (en) | Crystalline form b of an anthranilamide insecticide and conversion of form b into form a | |
CN101621926A (zh) | 3-(e)-2-{2-[6-(2-氰基苯氧基)嘧啶-4-基氧基]-苯基}-3-甲氧基-丙烯酸酯的多晶型物 | |
EP2280009A1 (en) | Nitrogenous heterocyclic compounds and fungicides for agricultural and horticultural use | |
US20110144374A1 (en) | Oxime ether derivative and fungicide for agriculture and horticulture | |
WO1993008167A1 (en) | Novel heterocyclic derivative and agrohorticultural bactericide containing same | |
CN111423472A (zh) | 广谱杀菌低毒低残留促生长噻森锰锌化合物及其组合物 | |
JP4561245B2 (ja) | クロモン化合物及びその用途 | |
JPWO2006137389A1 (ja) | 新規殺虫、殺ダニ剤 | |
JP2013256478A (ja) | フルミオキサジンの結晶形 | |
JP5748641B2 (ja) | 1,5−ナフチリジン誘導体およびそれを有効成分として含んでなる殺虫剤 | |
JP6112724B2 (ja) | 1,5−ナフチリジン誘導体およびそれを有効成分として含んでなる殺虫剤 | |
JP2013006771A (ja) | オキシムエーテル誘導体またはその塩、並びに農園芸用殺菌剤 | |
GB2611348A (en) | A crystalline form of diflufenican, a process for its preparation and use of the same | |
JP4939956B2 (ja) | 新規有害生物防除剤 | |
JP5675646B2 (ja) | 安定化された水性懸濁状農薬用組成物 | |
JPH08269055A (ja) | 2−フェノキシ−6−チエニルメチルオキシピリジン誘導体、その製造方法および除草剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180020111.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11747310 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2790921 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012501777 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 221605 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011218939 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 20127024395 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 8137/DELNP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011747310 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012140431 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: 2011218939 Country of ref document: AU Date of ref document: 20110222 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13580550 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012021146 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012021146 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120823 |